Rac1 overexpression is correlated with epithelial mesenchymal transition and predicts poor prognosis in non-small cell lung cancer

被引:58
作者
Zhou, Yujuan
Liao, Qianjin
Han, Yaqian
Chen, Jie
Liu, Zhigang
Ling, Hang
Zhang, Jing
Yang, Wenjuan
Oyang, Linda
Xia, Longzheng
Wang, Li
Wang, Heran
Xue, Lei
Wang, Hui [1 ,2 ]
Hu, Bingqiang [1 ,2 ]
机构
[1] Cent South Univ, Hunan Canc Hosp, Key Lab Translat Radiat Oncol, 283 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, 283 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China
来源
JOURNAL OF CANCER | 2016年 / 7卷 / 14期
基金
中国国家自然科学基金;
关键词
non-small cell lung cancer; Rac1; epithelial-mesenchymal transition; prognosis; markers; radiotherapy; POTENTIAL THERAPEUTIC TARGET; RADIORESISTANT HEAD; GAMMA-IRRADIATION; INHIBITION; EXPRESSION; INVASION; REARRANGEMENTS; METASTASIS; STATISTICS; CARCINOMA;
D O I
10.7150/jca.16198
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Ras-related C3 botulinum toxin substrate1(Rac1) and epithelial mesenchymal transition (EMT) are key therapeutic targets in cancer. We investigated the clinical significance of Rac1 and markers of EMT expression in non-small cell lung cancer (NSCLC), and their possible correlation with EMT phenotype. Methods: Immunohistochemistry was used to assess the expression of Rac1, Snail1, Twist1, N-cadherin (N-cad), Vimentin (Vim), and E-cadherin (E-cad) in 153 NSCLC paraffin-embedded specimens and 45 normal specimens adjacent to tumors. The correlation of Rac1 and EMT markers with clinicopathological characteristics and the relationship between the protein levels and progression-free survival (PFS) and overall survival (OS) were analyzed. Results: Compared with non-tumor tissues, the NSCLC tissues showed marked elevation in the levels of Rac1, Snail1, Twist1, N-cad, and Vim levels, whereas the E-cad levels were significantly decreased (P < 0.05). The aberrant expression of Rac1 and EMT markers was significantly associated with TNM stage and metastasis (P < 0.05). Increased expression of Rac1 may be associated with poor OS and PFS compared with low expression (P<0.001 and P=0.004). Significant correlations were observed between the EMT markers expressed and OS or PFS(P<0.01). In addition, multivariate analysis indicated that the expression of Rac1, Snail1, Twist1, N-cad, Vim, and E-cad was an independent prognostic factor in NSCLC. Interestingly, Rac1 expression was positively correlated with Snail1, Twist1, N-cad, and Vim levels (r=0.563, r=0.440, r=0.247 r=0.536, P<0.01, respectively) and negatively correlated with E-cad levels (r=-0.464, P<0.001) in NSCLC tissues. Rac1, Twist, Snail1, Vim and N-cad were highly expressed in lung cancer patients resistant to radiotherapy, while E-cad was poorly expressed. Conclusion: Rac1 may promote NSCLC progression and metastasis via EMT, which may be considered as a potential therapeutic target.
引用
收藏
页码:2100 / 2109
页数:10
相关论文
共 50 条
[41]   HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer [J].
Wang, Yixuan ;
Li, Nan ;
Che, Shuanlong ;
Jin, Tiefeng ;
Piao, Junjie ;
Liu, Shuangping ;
Lin, Zhenhua .
TUMOR BIOLOGY, 2017, 39 (07)
[42]   Impact of Brachyury on epithelial-mesenchymal transitions and chemosensitivity in non-small cell lung cancer [J].
Xu, Ke ;
Liu, Bin ;
Liu, Yongyu .
MOLECULAR MEDICINE REPORTS, 2015, 12 (01) :995-1001
[43]   Overexpression of HP1γ is associated with poor prognosis in non-small cell lung cancer cell through promoting cell survival [J].
Zhou, Ji ;
Bi, Hui ;
Zhan, Ping ;
Chang, Cunjie ;
Xu, Chunhua ;
Huang, Xiaojing ;
Yu, Like ;
Yao, Xin ;
Yan, Jun .
TUMOR BIOLOGY, 2014, 35 (10) :9777-9785
[44]   High TBX2 expression predicts poor prognosis in non-small cell lung cancer [J].
Zhang, Z. ;
Guo, Y. .
NEOPLASMA, 2014, 61 (04) :476-480
[45]   Modelling reoxygenation effects in non-small cell lung cancer cell lines and showing epithelial-mesenchymal transition [J].
Kapeleris, Joanna ;
Bark, Juliana Muller ;
Ranjit, Shanon ;
Richard, Derek ;
Vela, Ian ;
O'Byrne, Kenneth ;
Punyadeera, Chamindie .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (12) :3501-3510
[46]   Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas [J].
Yang, Sun Ho ;
Baek, Hyun Ah ;
Lee, Ho Jin ;
Park, Ho Sung ;
Jang, Kyu Yun ;
Kang, Myoung Jae ;
Lee, Dong Geun ;
Lee, Yong Chul ;
Moon, Woo Sung ;
Chung, Myoung Ja .
ONCOLOGY REPORTS, 2010, 24 (02) :311-319
[47]   Overexpression of fibronectin type III domain containing 3B is correlated with epithelial-mesenchymal transition and predicts poor prognosis in lung adenocarcinoma [J].
Bian, Tingting ;
Zheng, Liangfeng ;
Jiang, Daishan ;
Liu, Jian ;
Zhang, Jianguo ;
Feng, Jia ;
Zhang, Qing ;
Qian, Li ;
Qiu, Hongmei ;
Liu, Yifei ;
Yao, Sumei .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (05) :3317-3326
[48]   Long non-coding RNA HOST2 predicts poor prognosis and promotes cell proliferation and invasion in non-small cell lung cancer [J].
Wang, Dongchang ;
Zhao, Yunxia ;
Zhao, Zhifang ;
Li, Yahua ;
Liu, Le ;
Chen, Gang .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (01) :157-165
[49]   FOXC2 promotes epithelial-mesenchymal transition and cisplatin resistance of non-small cell lung cancer cells [J].
He, Yuwen ;
Xie, Hui ;
Yu, Pengjiu ;
Jiang, Shunjun ;
Wei, Li .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (06) :1049-1059
[50]   CTHRC1 overexpression predicts poor survival and enhances epithelial-mesenchymal transition in colorectal cancer [J].
Ni, Shujuan ;
Ren, Fei ;
Xu, Midie ;
Tan, Cong ;
Weng, Weiwei ;
Huang, Zhaohui ;
Sheng, Weiqi ;
Huang, Dan .
CANCER MEDICINE, 2018, 7 (11) :5643-5654